Literature DB >> 5798400

A new approach to inoperable craniopharyngiomas.

A C Trippi, J T Garner, J T Kassabian, C H Shelden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5798400     DOI: 10.1016/0002-9610(69)90133-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  7 in total

Review 1.  Management of primary or recurring grossly cystic craniopharyngiomas by means of draining systems. Topic review and 6 case reports.

Authors:  R Spaziante; E De Divitiis; C Irace; P Cappabianca; F Caputi
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Sump drainage: a palliative manoeuvre for the treatment of craniopharyngioma.

Authors:  J Miles
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-02       Impact factor: 10.154

3.  Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas.

Authors:  T Liszczak; E P Richardson; J P Phillips; S Jacobson; P L Kornblith
Journal:  Acta Neuropathol       Date:  1978-09-15       Impact factor: 17.088

4.  Retreatment of recurrent cystic craniopharyngioma with chromic phosphorus P 32.

Authors:  P P Kumar; R R Good; F M Skultety; E O Jones; W K Chu
Journal:  J Natl Med Assoc       Date:  1986-06       Impact factor: 1.798

5.  The radiotherapy of cystic craniopharyngioma with intracystic installation of 90Y silicate colloid.

Authors:  J Julow; F Lányi; M Hajda; M Simkovics; I Arany; S Tóth; E Pásztor
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

6.  Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. A case report.

Authors:  A M Bremer; T Q Nguyen; R Balsys
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

7.  Intracystic irradiation for craniopharyngiomas.

Authors:  Jenő Viktor Julow
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.